| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.975 | 0.002 | 0.975 | Dopamine D2 antagonist | 0.584 0.004 DBMET00890 0.875 0.003 DBMET00891 | ||
| 0.971 | 0.002 | 0.971 | Dopamine antagonist | 0.602 0.004 DBMET00890 0.868 0.003 DBMET00891 | ||
| 0.962 | 0.002 | 0.979 | 5 Hydroxytryptamine 1A agonist | 0.979 0.002 DBMET00890 0.886 0.003 DBMET00891 | DBMET00890 | |
| 0.93 | 0.003 | 0.93 | 5 Hydroxytryptamine antagonist | 0.78 0.004 DBMET00890 0.732 0.004 DBMET00891 | ||
| 0.929 | 0.002 | 0.929 | 5 Hydroxytryptamine 1A antagonist | 0.627 0.004 DBMET00890 0.621 0.004 DBMET00891 | ||
| 0.927 | 0.002 | 0.927 | 5 Hydroxytryptamine 2 antagonist | 0.736 0.004 DBMET00890 0.76 0.003 DBMET00891 | ||
| 0.873 | 0.002 | 0.873 | 5 Hydroxytryptamine 2A antagonist | 0.665 0.003 DBMET00890 0.691 0.003 DBMET00891 | ||
| 0.869 | 0.003 | 0.869 | 5 Hydroxytryptamine 1 antagonist | 0.62 0.004 DBMET00890 0.522 0.004 DBMET00891 | ||
| 0.791 | 0.003 | 0.858 | 5 Hydroxytryptamine 1 agonist | 0.858 0.003 DBMET00890 0.653 0.004 DBMET00891 | DBMET00890 | |
| 0.778 | 0.004 | 0.778 | Alpha adrenoreceptor antagonist | 0.612 0.004 DBMET00890 0.521 0.005 DBMET00891 | ||
| 0.776 | 0.003 | 0.776 | 5 Hydroxytryptamine 2B antagonist | 0.729 0.003 DBMET00890 0.537 0.005 DBMET00891 | ||
| 0.697 | 0.003 | 0.697 | Alpha 1a adrenoreceptor antagonist | 0.512 0.004 DBMET00890 0.423 0.005 DBMET00891 | ||
| 0.675 | 0.004 | 0.675 | Alpha 1 adrenoreceptor antagonist | 0.516 0.005 DBMET00890 0.39 0.007 DBMET00891 | ||
| 0.669 | 0.004 | 0.704 | 5 Hydroxytryptamine 2C antagonist | 0.704 0.003 DBMET00890 0.418 0.005 DBMET00891 | DBMET00890 | |
| 0.635 | 0.004 | 0.854 | 5 Hydroxytryptamine agonist | 0.854 0.003 DBMET00890 0.468 0.005 DBMET00891 | DBMET00890 | |
| 0.586 | 0.005 | 0.846 | Antiadrenergic | 0.846 0.004 DBMET00890 0.423 0.008 DBMET00891 | DBMET00890 | |
| 0.585 | 0.005 | 0.846 | Adrenaline antagonist | 0.846 0.004 DBMET00890 0.422 0.007 DBMET00891 | DBMET00890 | |
| 0.53 | 0.004 | 0.745 | 5 Hydroxytryptamine 7 antagonist | 0.745 0.003 DBMET00890 0.288 0.006 DBMET00891 | DBMET00890 | |
| 0.521 | 0.043 | 0.521 | Analgesic | 0.379 0.094 DBMET00891 | ||
| 0.472 | 0.018 | 0.696 | HERG channel blocker | 0.696 0.005 DBMET00890 0.28 0.055 DBMET00891 | DBMET00890 | |
| 0.432 | 0.004 | 0.503 | Alpha 1d adrenoreceptor antagonist | 0.503 0.004 DBMET00890 0.272 0.006 DBMET00891 | DBMET00890 | |
| 0.43 | 0.005 | 0.43 | Dopamine D4 antagonist | 0.186 0.014 DBMET00890 0.143 0.018 DBMET00891 | ||
| 0.43 | 0.005 | 0.533 | Alpha 1b adrenoreceptor antagonist | 0.533 0.004 DBMET00890 0.227 0.012 DBMET00891 | DBMET00890 | |
| 0.415 | 0.005 | 0.415 | Sigma receptor antagonist | 0.195 0.009 DBMET00890 0.232 0.008 DBMET00891 | ||
| 0.427 | 0.023 | 0.675 | Potassium channel (Voltage-sensitive) blocker | 0.675 0.005 DBMET00890 0.258 0.064 DBMET00891 | DBMET00890 | |
| 0.362 | 0.084 | 0.574 | MAP kinase kinase 6 inhibitor | 0.574 0.008 DBMET00890 0.348 0.094 DBMET00891 | DBMET00890 | |
| 0.27 | 0.017 | 0.34 | MAP kinase kinase 3 inhibitor | 0.34 0.004 DBMET00890 0.254 0.028 DBMET00891 | DBMET00890 | |
| 0.239 | 0.004 | 0.288 | Sigma 1 receptor antagonist | 0.288 0.004 DBMET00890 0.111 0.005 DBMET00891 | DBMET00890 | |
| 0.214 | 0.006 | 0.497 | Alpha 1 adrenoreceptor agonist | 0.497 0.003 DBMET00890 0.078 0.024 DBMET00891 | DBMET00890 | |
| 0.214 | 0.009 | 0.648 | 5 Hydroxytryptamine 1F antagonist | 0.648 0.003 DBMET00890 0.115 0.025 DBMET00891 | DBMET00890 | |
| 0.207 | 0.013 | 0.249 | Acetylcholine agonist | 0.249 0.009 DBMET00890 0.095 0.05 DBMET00891 | DBMET00890 | |
| 0.206 | 0.017 | 0.206 | Alpha 2 adrenoreceptor antagonist | 0.197 0.018 DBMET00890 0.101 0.048 DBMET00891 | ||
| 0.217 | 0.035 | 0.239 | Acetylcholine M1 receptor antagonist | 0.239 0.028 DBMET00890 0.17 0.058 DBMET00891 | DBMET00890 | |
| 0.197 | 0.025 | 0.197 | Acetylcholine muscarinic antagonist | 0.154 0.041 DBMET00890 0.19 0.027 DBMET00891 | ||
| 0.174 | 0.014 | 0.174 | Glutamate receptor agonist | |||
| 0.171 | 0.013 | 0.256 | Dopamine D1 antagonist | 0.256 0.008 DBMET00890 0.086 0.03 DBMET00891 | DBMET00890 | |
| 0.173 | 0.018 | 0.242 | Alpha 2a adrenoreceptor antagonist | 0.242 0.01 DBMET00890 0.097 0.038 DBMET00891 | DBMET00890 | |
| 0.166 | 0.013 | 0.166 | Dopamine D3 antagonist | 0.121 0.02 DBMET00890 0.053 0.052 DBMET00891 | ||
| 0.197 | 0.048 | 0.197 | Cholinergic | |||
| 0.159 | 0.015 | 0.425 | Alpha adrenoreceptor agonist | 0.425 0.004 DBMET00890 | DBMET00890 | |
| 0.212 | 0.085 | 0.472 | Potassium channel blocker | 0.472 0.013 DBMET00890 | DBMET00890 | |
| 0.153 | 0.051 | 0.153 | Cholinergic antagonist | 0.15 0.052 DBMET00890 0.139 0.059 DBMET00891 | ||
| 0.151 | 0.05 | 0.151 | Acetylcholine antagonist | 0.148 0.051 DBMET00890 0.136 0.058 DBMET00891 | ||
| 0.125 | 0.03 | 0.125 | Histamine H1 receptor antagonist | 0.105 0.038 DBMET00890 | ||
| 0.107 | 0.016 | 0.316 | DNA gyrase inhibitor | 0.316 0.004 DBMET00890 0.104 0.017 DBMET00891 | DBMET00890 | |
| 0.101 | 0.017 | 0.153 | Acetylcholine muscarinic agonist | 0.153 0.01 DBMET00890 0.052 0.04 DBMET00891 | DBMET00890 | |
| 0.113 | 0.029 | 0.154 | Acetylcholine nicotinic agonist | 0.154 0.016 DBMET00890 | DBMET00890 | |
| 0.091 | 0.014 | 0.091 | Nicotinic alpha7 receptor agonist | 0.08 0.018 DBMET00890 | ||
| 0.082 | 0.015 | 0.145 | Acetylcholine M1 receptor agonist | 0.145 0.008 DBMET00890 0.042 0.031 DBMET00891 | DBMET00890 | |
| 0.069 | 0.007 | 0.083 | Acetylcholine M4 receptor agonist | 0.083 0.005 DBMET00890 | DBMET00890 | |
| 0.094 | 0.033 | 0.094 | Acetylcholine M4 receptor antagonist | 0.093 0.034 DBMET00890 | ||
| 0.076 | 0.015 | 0.081 | Acetylcholine M2 receptor agonist | 0.081 0.013 DBMET00890 0.061 0.028 DBMET00891 | DBMET00890 | |
| 0.077 | 0.023 | 0.098 | Nicotinic neuronal receptor agonist | 0.098 0.013 DBMET00890 | DBMET00890 | |
| 0.081 | 0.03 | 0.081 | Glutamate (mGluR) agonist | |||
| 0.079 | 0.029 | 0.079 | Cannabinoid CB1 receptor agonist | |||
| 0.074 | 0.027 | 0.074 | Acetylcholine M5 receptor antagonist | 0.073 0.029 DBMET00890 | ||
| 0.074 | 0.039 | 0.074 | Cannabinoid receptor agonist | |||
| 0.072 | 0.037 | 0.357 | 5 Hydroxytryptamine uptake inhibitor | 0.357 0.005 DBMET00890 | DBMET00890 | |
| 0.2 | 0.166 | 0.259 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.259 0.055 DBMET00890 | DBMET00890 | |
| 0.067 | 0.039 | 0.067 | Acetylcholine M2 receptor antagonist | |||
| 0.043 | 0.018 | 0.05 | Glucose-6-phosphate dehydrogenase inhibitor | 0.05 0.012 DBMET00890 0.046 0.015 DBMET00891 | DBMET00890 | |
| 0.041 | 0.02 | 0.041 | Glutamate (mGluR group II) agonist | |||
| 0.037 | 0.019 | 0.037 | Glutamate (mGluR2) agonist | |||
| 0.045 | 0.028 | 0.056 | Opioid kappa receptor agonist | 0.056 0.02 DBMET00891 | DBMET00891 | |
| 0.085 | 0.071 | 0.106 | Antihistaminic | 0.106 0.05 DBMET00890 | DBMET00890 | |
| 0.077 | 0.068 | 0.098 | Histamine antagonist | 0.098 0.049 DBMET00890 | DBMET00890 | |
| 0.039 | 0.035 | 0.039 | Dopamine D2 agonist | |||
| 0.05 | 0.058 | 0.156 | Adrenaline uptake inhibitor | 0.156 0.009 DBMET00890 | DBMET00890 | |
| 0.049 | 0.06 | 0.249 | 5 Hydroxytryptamine 2A agonist | 0.249 0.004 DBMET00890 | DBMET00890 | |
| 0.044 | 0.057 | 0.091 | 5 Hydroxytryptamine 3 antagonist | 0.091 0.02 DBMET00890 | DBMET00890 | |
| 0.023 | 0.051 | 0.043 | 5 Hydroxytryptamine 3B antagonist | 0.043 0.019 DBMET00890 | DBMET00890 | |
| 0.046 | 0.077 | 0.163 | 5 Hydroxytryptamine 1B antagonist | 0.163 0.011 DBMET00890 | DBMET00890 | |
| 0.022 | 0.059 | 0.04 | AMPA receptor agonist | 0.04 0.017 DBMET00890 | DBMET00890 | |
| 0.012 | 0.053 | 0.031 | Vasopressin 1A antagonist | 0.031 0.018 DBMET00890 | DBMET00890 | |
| 0.042 | 0.088 | 0.1 | Lipase inhibitor | 0.1 0.027 DBMET00890 | DBMET00890 | |
| 0.01 | 0.061 | 0.02 | Bombesin 3 receptor agonist | 0.02 0.011 DBMET00890 | DBMET00890 | |
| 0.016 | 0.071 | 0.034 | Nicotinic acid receptor agonist | 0.034 0.028 DBMET00890 | DBMET00890 | |
| 0.011 | 0.068 | 0.024 | Bombesin agonist | 0.024 0.013 DBMET00890 | DBMET00890 | |
| 0.01 | 0.073 | 0.028 | Vasopressin 1 antagonist | 0.028 0.027 DBMET00890 | DBMET00890 | |
| 0.013 | 0.077 | 0.022 | Factor XIII inhibitor | 0.022 0.012 DBMET00890 | DBMET00890 | |
| 0.036 | 0.107 | 0.115 | 5 Hydroxytryptamine 3A antagonist | 0.115 0.01 DBMET00890 | DBMET00890 | |
| 0.016 | 0.103 | 0.16 | DNA gyrase subunit B inhibitor | 0.16 0.004 DBMET00890 | DBMET00890 | |
| 0.029 | 0.134 | 0.094 | Factor IXa inhibitor | 0.094 0.011 DBMET00890 | DBMET00890 | |
| 0.06 | 0.172 | 0.125 | Proteasome inhibitor | 0.125 0.062 DBMET00890 | DBMET00890 | |
| 0.024 | 0.141 | 0.07 | H+/K+-transporting ATPase inhibitor | 0.07 0.017 DBMET00890 | DBMET00890 | |
| 0.053 | 0.173 | 0.094 | Alpha 2c adrenoreceptor antagonist | 0.094 0.072 DBMET00890 | DBMET00890 | |
| 0.02 | 0.145 | 0.129 | 5 Hydroxytryptamine 2 agonist | 0.129 0.006 DBMET00890 | DBMET00890 | |
| 0.024 | 0.151 | 0.071 | Cyclin-dependent kinase 6 inhibitor | 0.071 0.03 DBMET00890 | DBMET00890 | |
| 0.141 | 0.274 | 0.246 | Insulysin inhibitor | 0.246 0.1 DBMET00890 | DBMET00890 | |
| 0.024 | 0.168 | 0.043 | DNA gyrase subunit A inhibitor | 0.043 0.027 DBMET00890 | DBMET00890 | |
| 0.029 | 0.192 | 0.109 | 5 Hydroxytryptamine 3 agonist | 0.109 0.012 DBMET00890 | DBMET00890 | |
| 0.018 | 0.184 | 0.184 | 5 Hydroxytryptamine 6 antagonist | 0.184 0.004 DBMET00890 | DBMET00890 | |
| 0.053 | 0.219 | 0.149 | Interleukin 1b antagonist | 0.149 0.041 DBMET00890 | DBMET00890 | |
| 0.017 | 0.192 | 0.071 | Acetylcholine M5 receptor agonist | 0.071 0.043 DBMET00890 | DBMET00890 | |
| 0.008 | 0.193 | 0.017 | Antibiotic Tetracycline-like | 0.017 0.006 DBMET00891 | DBMET00891 | |
| 0.11 | 0.298 | 0.224 | Hypoxia-inducible factor 1 alpha inhibitor | 0.224 0.125 DBMET00891 | DBMET00891 | |
| 0.016 | 0.214 | 0.152 | 5 Hydroxytryptamine 1D antagonist | 0.152 0.012 DBMET00890 | DBMET00890 | |
| 0.101 | 0.302 | 0.273 | Transcription factor NF kappa B inhibitor | 0.273 0.111 DBMET00890 | DBMET00890 | |
| 0.068 | 0.27 | 0.248 | Hexokinase inhibitor | 0.248 0.017 DBMET00890 | DBMET00890 | |
| 0.044 | 0.249 | 0.129 | AMP-activated protein kinase stimulant | 0.129 0.042 DBMET00890 | DBMET00890 | |
| 0.016 | 0.222 | 0.07 | Nicotinic receptor alpha7 subunit antagonist | 0.07 0.021 DBMET00890 | DBMET00890 | |
| 0.04 | 0.252 | 0.107 | Alpha 2b adrenoreceptor antagonist | 0.107 0.069 DBMET00890 | DBMET00890 | |
| 0.028 | 0.242 | 0.238 | M18 aspartyl aminopeptidase inhibitor | 0.238 0.023 DBMET00890 | DBMET00890 | |
| 0.02 | 0.243 | 0.047 | Histamine H4 receptor antagonist | 0.047 0.036 DBMET00890 | DBMET00890 | |
| 0.007 | 0.23 | 0.141 | 5 Hydroxytryptamine 2C agonist | 0.141 0.005 DBMET00890 | DBMET00890 | |
| 0.18 | 0.426 | 0.371 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.371 0.128 DBMET00890 | DBMET00890 | |
| 0.014 | 0.264 | 0.061 | Alpha 2 adrenoreceptor agonist | 0.061 0.041 DBMET00890 | DBMET00890 | |
| 0.015 | 0.271 | 0.044 | Phenylethanolamine N methyltransferase inhibitor | 0.044 0.022 DBMET00890 | DBMET00890 | |
| 0.06 | 0.324 | 0.165 | Spasmolytic | 0.165 0.149 DBMET00890 | DBMET00890 | |
| 0.014 | 0.28 | 0.059 | Neuronal nicotinic receptor antagonist | 0.059 0.056 DBMET00890 | DBMET00890 | |
| 0.02 | 0.309 | 0.055 | Alpha 1L adrenoreceptor agonist | 0.055 0.011 DBMET00890 | DBMET00890 | |
| 0.117 | 0.419 | 0.205 | 5 Hydroxytryptamine 3E antagonist | 0.205 0.055 DBMET00890 | DBMET00890 | |
| 0.03 | 0.332 | 0.182 | 5 Hydroxytryptamine 3A agonist | 0.182 0.021 DBMET00890 | DBMET00890 | |
| 0.012 | 0.316 | 0.048 | 5 Hydroxytryptamine 2B agonist | 0.048 0.015 DBMET00890 | DBMET00890 | |
| 0.006 | 0.314 | 0.022 | Alpha 1a adrenoreceptor agonist | 0.022 0.016 DBMET00890 | DBMET00890 | |
| 0.095 | 0.403 | 0.131 | Ca2+-transporting ATPase inhibitor | 0.131 0.117 DBMET00890 | DBMET00890 | |
| 0.039 | 0.35 | 0.138 | Toll-Like receptor antagonist | 0.138 0.065 DBMET00890 | DBMET00890 | |
| 0.021 | 0.338 | 0.097 | Adrenaline agonist | 0.097 0.039 DBMET00890 | DBMET00890 | |
| 0.117 | 0.441 | 0.234 | 5 Hydroxytryptamine uptake stimulant | 0.234 0.099 DBMET00890 | DBMET00890 | |
| 0.039 | 0.367 | 0.087 | Alpha 2d adrenoreceptor antagonist | 0.087 0.079 DBMET00890 | DBMET00890 | |
| 0.082 | 0.417 | 0.321 | 5 Hydroxytryptamine release stimulant | 0.321 0.064 DBMET00890 | DBMET00890 | |
| 0.014 | 0.356 | 0.073 | Protein kinase C beta inhibitor | 0.073 0.043 DBMET00890 | DBMET00890 | |
| 0.026 | 0.368 | 0.132 | GABA C receptor agonist | 0.132 0.042 DBMET00890 | DBMET00890 | |
| 0.033 | 0.385 | 0.082 | MAP kinase kinase 7 inhibitor | 0.082 0.04 DBMET00890 | DBMET00890 | |
| 0.006 | 0.364 | 0.044 | Dopamine D5 agonist | 0.044 0.022 DBMET00890 | DBMET00890 | |
| 0.024 | 0.382 | 0.162 | Toll-Like receptor 9 antagonist | 0.162 0.055 DBMET00890 | DBMET00890 | |
| 0.051 | 0.427 | 0.212 | 5 Hydroxytryptamine 1E antagonist | 0.212 0.117 DBMET00890 | DBMET00890 | |
| 0.02 | 0.403 | 0.096 | Caspase 7 inhibitor | 0.096 0.033 DBMET00890 | DBMET00890 | |
| 0.019 | 0.402 | 0.127 | Urease inhibitor | 0.127 0.038 DBMET00890 | DBMET00890 | |
| 0.037 | 0.424 | 0.163 | Interleukin 1 antagonist | 0.163 0.05 DBMET00890 | DBMET00890 | |
| 0.035 | 0.44 | 0.186 | Cyclin-dependent kinase 8 inhibitor | 0.186 0.046 DBMET00890 | DBMET00890 | |
| 0.024 | 0.435 | 0.134 | Cytidine deaminase inhibitor | 0.134 0.088 DBMET00890 | DBMET00890 | |
| 0.01 | 0.448 | 0.089 | Pim-3 kinase inhibitor | 0.089 0.06 DBMET00890 | DBMET00890 | |
| 0.005 | 0.451 | 0.049 | Alpha 1d adrenoreceptor agonist | 0.049 0.017 DBMET00890 | DBMET00890 | |
| 0.013 | 0.469 | 0.073 | Phospholipase D inhibitor | 0.073 0.046 DBMET00890 | DBMET00890 | |
| 0.082 | 0.545 | 0.255 | Tyrosine 3 hydroxylase inhibitor | 0.255 0.063 DBMET00890 | DBMET00890 | |
| 0.025 | 0.491 | 0.137 | Mannose-6-phosphate isomerase inhibitor | 0.137 0.077 DBMET00890 | DBMET00890 | |
| 0.006 | 0.478 | 0.043 | Histamine H1 receptor agonist | 0.043 0.031 DBMET00890 | DBMET00890 | |
| 0.004 | 0.477 | 0.029 | 5 Hydroxytryptamine 6 agonist | 0.029 0.02 DBMET00890 | DBMET00890 | |
| 0.003 | 0.481 | 0.023 | Imidazoline I1 receptor antagonist | 0.023 0.012 DBMET00890 | DBMET00890 | |
| 0.015 | 0.495 | 0.132 | Protein kinase C mu inhibitor | 0.132 0.035 DBMET00890 | DBMET00890 | |
| 0.01 | 0.495 | 0.044 | Potassium channel (ATP-sensitive) activator | 0.044 0.043 DBMET00890 | DBMET00890 | |
| 0.069 | 0.556 | 0.26 | Calcium channel activator | 0.26 0.136 DBMET00890 | DBMET00890 | |
| 0.01 | 0.498 | 0.046 | Potassium channel (Inward rectifier) activator | 0.046 0.044 DBMET00890 | DBMET00890 | |
| 0.028 | 0.544 | 0.201 | Aldehyde oxidase inhibitor | 0.201 0.104 DBMET00890 | DBMET00890 | |
| 0.024 | 0.545 | 0.149 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.149 0.129 DBMET00890 | DBMET00890 | |
| 0.02 | 0.541 | 0.049 | Alpha 1b adrenoreceptor agonist | 0.049 0.037 DBMET00890 | DBMET00890 | |
| 0.078 | 0.607 | 0.316 | Caspase 9 stimulant | 0.316 0.177 DBMET00890 | DBMET00890 | |
| 0.013 | 0.548 | 0.056 | Glucosylceramidase inhibitor | 0.056 0.036 DBMET00890 | DBMET00890 | |
| 0.018 | 0.556 | 0.109 | Alpha-N-acetylglucosaminidase inhibitor | 0.109 0.089 DBMET00890 | DBMET00890 | |
| 0.014 | 0.561 | 0.134 | Ribosomal protein S6 kinase inhibitor | 0.134 0.078 DBMET00890 | DBMET00890 | |
| 0.011 | 0.572 | 0.114 | MAP kinase kinase 1 inhibitor | 0.114 0.041 DBMET00890 | DBMET00890 | |
| 0.022 | 0.612 | 0.188 | DNA synthesis inhibitor | 0.188 0.142 DBMET00890 | DBMET00890 | |
| 0.009 | 0.611 | 0.117 | Protein kinase C delta inhibitor | 0.117 0.039 DBMET00890 | DBMET00890 | |
| 0.023 | 0.627 | 0.105 | NADPH oxidase inhibitor | 0.105 0.104 DBMET00890 | DBMET00890 | |
| 0.017 | 0.628 | 0.117 | Activin receptor-like kinase 2 inhibitor | 0.117 0.1 DBMET00890 | DBMET00890 | |
| 0.047 | 0.666 | 0.349 | GABA C receptor rho-3 antagonist | 0.349 0.086 DBMET00890 | DBMET00890 | |
| 0.008 | 0.646 | 0.117 | MAP kinase kinase inhibitor | 0.117 0.076 DBMET00890 | DBMET00890 | |
| 0.032 | 0.672 | 0.198 | Superoxide dismutase inhibitor | 0.198 0.119 DBMET00890 | DBMET00890 | |
| 0.011 | 0.652 | 0.14 | Death-associated protein kinase 3 inhibitor | 0.14 0.139 DBMET00890 | DBMET00890 | |
| 0.009 | 0.702 | 0.097 | GABA C receptor antagonist | 0.097 0.083 DBMET00890 | DBMET00890 | |
| 0.019 | 0.714 | 0.13 | GABA C receptor rho-2 antagonist | 0.13 0.106 DBMET00890 | DBMET00890 | |
| 0.01 | 0.721 | 0.096 | GABA C receptor rho-1 antagonist | 0.096 0.068 DBMET00890 | DBMET00890 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |